title: Ketamine reduces lidocaine-induced seizures in mice.
abstract: Systemic toxic reactions to local anesthetics are brought about by absolute overdosage, and, most commonly, inadvertent intravascular injections. The anti-convulsant action of ketamine has been studied. However, the effect of ketamine on lidocaine-induced convulsions has not been reported. This study investigated the effect of ketamine on lidocaine-induced seizures in mice. Mice (32-41 g) were divided into 2 groups, 15 in each group, and were pretreated with intraperitoneal normal saline solution or intraperitenoeal (ip) ketamine before lidocaine. Group 1 (N = 15) received 75 mg kg ip lidocaine; Group 2 (N = 15) received 20 mg kg ketamin ip; 5 min later 75 mg kg lidokaine ip were applied. Clinical features, incidences, latencies, durations, and mortality rate of convulsions were recorded. After 75 mg kg lidocaine injection, ataxia, loss of righting reflex, and generalized tonic-clonic convulsions were seen within 2-5 min in Group 1. Generalized tonic-clonic convulsions were seen in 8 mice and deep sedation was seen in 7 mice in Group 2 (p < .05). Generalized status epilepticus occurred in one mouse in both groups. Three mice from Group l and one mouse from Group 2 died during convulsions. There were no differences between the two groups with regard to the onset and duration of seizures (p > .05). It was concluded that ketamine significantly prevented lidocaine-induced generalized tonic-clonic seizures; on the other hand, the lethality of lidocaine was least reduced by ketamine.
authors.affiliation: Department of Anesthesiology, Erciyes University, Medical Faculty, Kayseri, Turkey.
authors.forename: Gulen
authors.initials: G
authors.lastname: Guler
authors.forename: Fusun
authors.initials: F
authors.lastname: Erdogan
authors.forename: Asuman
authors.initials: A
authors.lastname: Golgeli
authors.forename: Aynur
authors.initials: A
authors.lastname: Akin
authors.forename: Adem
authors.initials: A
authors.lastname: Boyaci
mesh_terms: D000779:Anesthetics, Local / Q000009:adverse effects*; D000818:Animals; D018691:Excitatory Amino Acid Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D007274:Injections, Intraperitoneal; D007649:Ketamine / Q000008:administration & dosage / Q000627:therapeutic use*; D008012:Lidocaine / Q000009:adverse effects*; D008297:Male; D051379:Mice; D011897:Random Allocation; D012640:Seizures / Q000139:chemically induced* / Q000188:drug therapy*
chemical_list: D000779:Anesthetics, Local; D018691:Excitatory Amino Acid Antagonists; D007649:Ketamine; D008012:Lidocaine